Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 90 clinical trials
  • 0 views
  • 19 Apr, 2022
  • 1 location
HCQ for Non Europeans With Mild to Severe UC

The objective of this study is to assess the efficacy of hydroxychloroquine (HCQ) when combined with Mesalamine in reducing clinical and histologic disease activity in patients who have active

remission
mesalamine
hematochezia
endoscopy
  • 0 views
  • 22 Mar, 2022
  • 1 location
Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia.

Colchicine acts upstream in the cytokines cascade by inhibiting the NLRP3 inflammasome while IL-6 receptor antagonists (tocilizumab) block the end result of the cytokines cascade. Hence, adding colchicine to tocilizumab with the aim of blocking the early and end products of the cytokines cascade, might reduce the risk of developing …

  • 0 views
  • 10 Dec, 2021
  • 1 location
A Study of Hydroxychloroquine Vitamin C Vitamin D and Zinc for the Prevention of COVID-19 Infection

This is a Phase II interventional study testing whether treatment with hydroxychloroquine, Vitamin C, Vitamin D, and Zinc can prevent symptoms of COVID-19

hydroxychloroquine
vitamin d
zinc
Accepts healthy volunteers
covid-19
  • 394 views
  • 27 Oct, 2021
  • 1 location
A Study of Quintuple Therapy to Treat COVID-19 Infection

This is a Phase II interventional study will test the efficacy of quintuple therapy (Hydroxychloroquine, Azithromycin, Vitamin C, Vitamin D, and Zinc) in the treatment of patients with COVID-19

hydroxychloroquine
vitamin d
azithromycin
zinc
covid-19
  • 61 views
  • 12 Sep, 2021
  • 1 location
Randomised Evaluation of COVID-19 Therapy (RECOVERY)

RECOVERY is a randomised trial investigating whether treatment with Lopinavir-Ritonavir, Hydroxychloroquine, Corticosteroids, Azithromycin, Colchicine, IV Immunoglobulin (children only

fever
hydroxychloroquine
influenza
corticosteroids
lopinavir
  • 0 views
  • 19 Apr, 2022
  • 6 locations
Trial of Treatments for COVID-19 in Hospitalized Adults (DisCoVeRy)

and hydroxychloroquine were evaluated as potential treatments for COVID-19. These treatments have been discontinued based on analyses review by both DSMC/DSMB, the Solidarity Executive Group and the

hydroxychloroquine
mechanical ventilation
SARS
lopinavir
lopinavir/ritonavir
  • 405 views
  • 29 Jun, 2022
  • 42 locations
Outpatient Treatment With Anti-Coronavirus Immunoglobulin (OTAC)

The primary objective of the Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC) (INSIGHT 012) trial is to compare the safety and efficacy of a single infusion of anti-COVID-19 hyperimmune intravenous immunoglobulin (hIVIG) versus placebo among adults with recently diagnosed SARS-CoV-2 infection who do not require hospitalization. The primary endpoint of this …

  • 0 views
  • 24 Apr, 2022
  • 34 locations
SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer

Trial Phase: Phase III: Interventional Trial: Virtual clinics to deliver universal interventions to maintain and improve physical health, nutritional state and psychological wellbeing in people with cancer who are following social distancing guidance: A COVID-19 targeted trial. Indication: Male or female participants, aged over 18 years old with suspicion or …

covid-19
primary cancer
cancer
nutritional support
  • 0 views
  • 16 Jun, 2022
  • 1 location
Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)

This study is designed to test the efficacy and safety of combinations of two well-understood agents - famotidine and celecoxib. Each of these agents separately demonstrate clinical activity in mitigating COVID-19 disease symptoms or severity, and each of which appear to have separate and complementary mechanisms of action.

  • 0 views
  • 16 Jun, 2022
  • 14 locations